Lexicon Pharmaceuticals
LXRX
LXRX
107 hedge funds and large institutions have $710M invested in Lexicon Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 29
2.25% less ownership
Funds ownership: 86.24% → 83.99% (-2.2%)
Holders
107
Holding in Top 10
2
Calls
$2.58M
Puts
$1.35M
Top Buyers
| 1 | +$7.12M | |
| 2 | +$5.69M | |
| 3 | +$5.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.72M |
| 5 |
Two Sigma Investments
New York
|
+$2.76M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$8.07M | |
| 3 | -$7.23M | |
| 4 |
Millennium Management
New York
|
-$4.37M |
| 5 |
Renaissance Technologies
New York
|
-$4.01M |